EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis

Fangyu Liu iD, Thomas R Austin, Jennifer A Schrack, Jingsha Chen, Jeremy Walston, Rasika A Mathias, Morgan Grams, Michelle C Odden iD, Anne Newman, Bruce M Psaty, Diego Ramonfaur, Amil M Shah und 3 weitere

Aging Cell · 2023-11 · 22 (11)

DOI: 10.1111/acel.13975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 11.09.2023. Verfasst von Fangyu Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Frailty. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteomic approaches have unique advantages in the identification of biological pathways that influence physical frailty, a multifactorial geriatric syndrome predictive of adverse health outcomes in older adults. To date, proteomic studies of frailty are scarce, and few evaluated prefrailty as a separate state or examined predictors of incident frailty. Using plasma proteins measured by 4955 SOMAmers in the Atherosclerosis Risk in Community study, we identified 134 and 179 proteins cross‐sectionally associated with prefrailty and frailty, respectively, after Bonferroni correction ( p < 1 × 10 −5 ) among 3838 older adults aged ≥65 years, adjusting for demographic and physiologic factors and chronic diseases. Among them, 23 (17%) and 82 (46%) were replicated in the Cardiovascular Health Study using the same models (FDR p < 0.05). Notably, higher odds of prefrailty and frailty were observed with higher levels of growth differentiation factor 15 (GDF15; p prefrailty = 1 × 10 −15 , p frailty = 2 × 10 −19 ), transgelin (TAGLN; p prefrailty = 2 × 10 −12 , p frailty = 6 × 10 −22 ), and insulin‐like growth factor‐binding protein 2 (IGFBP2; p prefrailty = 5 × 10 −15 , p frailty = 1 × 10 −15 ) and with a lower level of growth hormone receptor (GHR, p prefrailty = 3 × 10 −16 , p frailty = 2 × 10 −18 ). Longitudinally, we identified 4 proteins associated with incident frailty ( p < 1 × 10 −5 ). Higher levels of triggering receptor expressed on myeloid cells 1 (TREM1), TAGLN, and heart and adipocyte fatty‐acid binding proteins predicted incident frailty. Differentially regulated proteins were enriched in pathways and upstream regulators related to lipid metabolism, angiogenesis, inflammation, and cell senescence. Our findings provide a set of plasma proteins and biological mechanisms that were dysregulated in both the prodromal and the clinical stage of frailty, offering new insights into frailty etiology and targets for intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyHumansAgedProteomicsInflammationSyndromeBlood ProteinsFrail Elderly

Stichwörter der Autor:innen

agingfrailtylate lifeproteomics

Substanzen

Blood Proteins

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Center on Aging and Health, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Precision Medicine, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Fangyu Liu, Michelle C Odden

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Liu, F., Austin, T. R., Schrack, J. A., Chen, J., Walston, J., Mathias, R. A., Grams, M., Odden, M. C., Newman, A., Psaty, B. M., Ramonfaur, D., Shah, A. M., Windham, B. G., Coresh, J., & Walker, K. A. (2023). Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis. Aging Cell, 22(11). https://doi.org/10.1111/acel.13975

Vancouver

Liu F, Austin TR, Schrack JA, Chen J, Walston J, Mathias RA, et al. Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis. Aging Cell. 2023;22(11). doi:10.1111/acel.13975

BibTeX
@article{Liu2023,
  author = {Liu, Fangyu and Austin, Thomas R and Schrack, Jennifer A and Chen, Jingsha and Walston, Jeremy and Mathias, Rasika A and Grams, Morgan and Odden, Michelle C and Newman, Anne and Psaty, Bruce M and Ramonfaur, Diego and Shah, Amil M and Windham, B Gwen and Coresh, Josef and Walker, Keenan A},
  title = {Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis},
  journal = {Aging Cell},
  year = {2023},
  volume = {22},
  number = {11},
  doi = {10.1111/acel.13975}
}
Kostenlos starten →